118 related articles for article (PubMed ID: 1760904)
21. Early pulmonary toxicity after administration of high-dose BCNU.
Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
[TBL] [Abstract][Full Text] [Related]
22. 25-year study of lung fibrosis following carmustine therapy for brain tumor in childhood.
Lohani S; O'Driscoll BR; Woodcock AA
Chest; 2004 Sep; 126(3):1007. PubMed ID: 15364795
[No Abstract] [Full Text] [Related]
23. Pulmonary toxicity in long-term administration of BCNU.
Holoye PY; Jenkins DE; Greenberg SD
Cancer Treat Rep; 1976 Nov; 60(11):1691-4. PubMed ID: 1021241
[No Abstract] [Full Text] [Related]
24. Fatal pneumothorax in "BCNU lung".
Wilson KS; Brigden ML; Alexander S; Worth A
Med Pediatr Oncol; 1982; 10(2):195-9. PubMed ID: 7070355
[TBL] [Abstract][Full Text] [Related]
25. Late carmustine lung fibrosis. Age at treatment may influence severity and survival.
O'Driscoll BR; Kalra S; Gattamaneni HR; Woodcock AA
Chest; 1995 May; 107(5):1355-7. PubMed ID: 7750330
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
Durant JR; Norgard MJ; Murad TM; Bartolucci AA; Langford KH
Ann Intern Med; 1979 Feb; 90(2):191-4. PubMed ID: 443651
[TBL] [Abstract][Full Text] [Related]
27. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
Jones RB; Matthes S; Shpall EJ; Fisher JH; Stemmer SM; Dufton C; Stephens JK; Bearman SI
J Natl Cancer Inst; 1993 Apr; 85(8):640-7. PubMed ID: 8468721
[TBL] [Abstract][Full Text] [Related]
28. Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study.
Adams DM; Zhou T; Berg SL; Bernstein M; Neville K; Blaney SM;
Pediatr Blood Cancer; 2008 Mar; 50(3):549-53. PubMed ID: 17941066
[TBL] [Abstract][Full Text] [Related]
29. Rapidly progressive, fatal pulmonary fibrosis induced by carmustine.
Patten GA; Billi JE; Rotman HH
JAMA; 1980 Aug; 244(7):687-8. PubMed ID: 7392168
[No Abstract] [Full Text] [Related]
30. BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes.
Mitsudo SM; Greenwald ES; Banerji B; Koss LG
Cancer; 1984 Aug; 54(4):751-5. PubMed ID: 6744207
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients.
Jungk C; Chatziaslanidou D; Ahmadi R; Capper D; Bermejo JL; Exner J; von Deimling A; Herold-Mende C; Unterberg A
BMC Cancer; 2016 Feb; 16():81. PubMed ID: 26865253
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.
Suratt BT; Lynch DA; Cool CD; Jones RB; Brown KK
Bone Marrow Transplant; 2003 May; 31(10):939-41. PubMed ID: 12748674
[TBL] [Abstract][Full Text] [Related]
33. Carmustine toxicity presenting as a lobar infiltrate.
Patterson DL; Wiemann MC; Lee TH; Byron WA
Chest; 1993 Jul; 104(1):315-7. PubMed ID: 8325102
[TBL] [Abstract][Full Text] [Related]
34. [Progressive pulmonary fibrosis due to combined treatment with BCNU, cyclophosphospahmide and cytosin-arabinoside (author's transl)].
Bargon G; Anger B; Schreml W; Kubanek W; Heimpel H
Rofo; 1978 Sep; 129(3):312-6. PubMed ID: 151043
[TBL] [Abstract][Full Text] [Related]
35. Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
Helal GK; Helal OK
Arch Toxicol; 2009 Jan; 83(1):87-94. PubMed ID: 18528683
[TBL] [Abstract][Full Text] [Related]
36. [Fatal pulmonary fibrosis induced by cytotoxic therapy].
Somló P; Révész T
Orv Hetil; 1984 May; 125(19):1143-5. PubMed ID: 6718003
[No Abstract] [Full Text] [Related]
37. The pulmonary toxicity of antineoplastic agents.
Ginsberg SJ; Comis RL
Semin Oncol; 1982 Mar; 9(1):34-51. PubMed ID: 6176027
[No Abstract] [Full Text] [Related]
38. Treatment of grade III and IV astrocytomas with BCNU alone and in combination with VM-26 following surgery and radiation therapy.
Sweet DL; Hendler FJ; Hanlon K; Hekmatpanah J; Griem ML; Duda EE; Mulligan B; Wollman RL
Cancer Treat Rep; 1979; 63(11-12):1707-11. PubMed ID: 230893
[TBL] [Abstract][Full Text] [Related]
39. Delayed pulmonary fibrosis after nitrosourea therapy.
Limper AH; McDonald JA
N Engl J Med; 1990 Aug; 323(6):407-9. PubMed ID: 2370891
[No Abstract] [Full Text] [Related]
40. Carmustine and the lungs .
Schmitz N; Diehl V
Lancet; 1997 Jun; 349(9067):1712-3. PubMed ID: 9193378
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
